My Bibliography

select

Wang Z, Kwan ML, Haque R, Pratt R, Lee VS, Roh JM, Ergas IJ, Cannavale KL, Loo RK, Aaronson DS, Quesenberry CP, Ambrosone CB, Kushi LH, Tang L. Environmental and occupational exposures and prognosis in patients with non-muscle invasive bladder cancer in the Be-Well study. American journal of epidemiology. Forthcoming.

select

Chlebowski RT, Aragaki AK, Pan K, Simon MS, Neuhouser ML, Haque R, Rohan TE, Wactawski-Wende J, Orchard TS, Mortimer JE, Lane D, Kaunitz AM, Desai P, Wild RA, Barac A, Manson JE. Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative. Cancer. 2024 Sep 15;130(18):3147-3156. doi: 10.1002/cncr.35318. Epub 2024 May 13. PubMed PMID: 38736319.

select

Kwan ML, Wang Z, Haque R, Lee VS, Roh JM, Ergas IJ, Cannavale KL, Pratt R, Goniewicz M, Loo RK, Aaronson DS, Quesenberry CP Jr, Zhang Y, Ambrosone CB, Kushi LH, Tang L. The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Guérin in Treating Nonmuscle-Invasive Bladder Cancer. J Urol. 2024 Sep;212(3):420-430. doi: 10.1097/JU.0000000000004070. Epub 2024 Jun 7. PubMed PMID: 38848543; PubMed Central PMCID: PMC11309891.

select

Chlebowski RT, Aragaki AK, Pan K, Haque R, Rohan TE, Song M, Wactawski-Wende J, Lane DS, Harris HR, Strickler H, Kauntiz AM, Runowicz CD. Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials. J Clin Oncol. 2024 Aug 22;:JCO2301918. doi: 10.1200/JCO.23.01918. [Epub ahead of print] PubMed PMID: 39173088.

select

Wang Z, Kwan ML, Haque R, Pratt R, Lee VS, Roh JM, Ergas IJ, Cannavale KL, Loo RK, Aaronson DS, Quesenberry CP, Ambrosone CB, Kushi LH, Tang L. Environmental and occupational exposures and prognosis in patients with non-muscle-invasive bladder cancer in the Be-Well Study. Am J Epidemiol. 2024 Jun 3;193(6):863-873. doi: 10.1093/aje/kwad236. PubMed PMID: 38055616; PubMed Central PMCID: PMC11466861.

select

Wang Z, Kwan ML, Haque R, Singh PK, Goniewicz M, Pratt R, Lee VS, Roh JM, Ergas IJ, Cannavale KL, Loo RK, Aaronson DS, Quesenberry CP, Zhang Y, Ambrosone CB, Kushi LH, Tang L. Modifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study. Mol Nutr Food Res. 2024 Apr;68(8):e2400087. doi: 10.1002/mnfr.202400087. Epub 2024 Apr 6. PubMed PMID: 38581346; PubMed Central PMCID: PMC11272391.

select

Patel J, Attaluri V, Basam M, Ryoo J, Wu D, Mukherjee A, Chung J, Cooper RM, Haque R. Investigating Mortality Disparities Among Insured Patients With Colon Cancer Treated in an Integrated Health care System and Other Private Settings. Am Surg. 2023 Dec;89(12):5940-5948. doi: 10.1177/00031348221146950. Epub 2023 Jun 2. PubMed PMID: 37265450.

select

Mukherjee A, Gu Z, Chen LH, Potosky AL, Haque R. Association of metabolic syndrome conditions with risk of second primary uterine cancer in breast cancer survivors. J Cancer Res Clin Oncol. 2023 Dec;149(20):17749-17755. doi: 10.1007/s00432-023-05489-1. Epub 2023 Nov 4. PubMed PMID: 37925391.

select

Vasbinder A, Zaslavsky O, Heckbert SR, Thompson H, Cheng RK, Saquib N, Wallace R, Haque R, Paskett ED, Reding KW. Associations of Health-Related Quality of Life and Sleep Disturbance With Cardiovascular Disease Risk in Postmenopausal Breast Cancer Survivors. Cancer Nurs. 2023 Nov-Dec 01;46(6):E355-E364. doi: 10.1097/NCC.0000000000001133. Epub 2022 Dec 1. PubMed PMID: 35816026; PubMed Central PMCID: PMC10232669.

select

Haque R, Chen LH, Oestreicher N, Lalla D, Chlebowski RT. Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan. Breast Cancer (Dove Med Press). 2023;15:637-645. doi: 10.2147/BCTT.S420061. eCollection 2023. PubMed PMID: 37605715; PubMed Central PMCID: PMC10440088.

select

Wang Z, Kwan ML, Haque R, Goniewicz M, Pratt R, Lee VS, Roh JM, Ergas IJ, Cannavale KL, Loo RK, Aaronson DS, Quesenberry CP, Zhang Y, Ambrosone CB, Kushi LH, Tang L. Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings from the Be-Well Study. Am J Clin Nutr. 2023 Jun;117(6):1110-1120. doi: 10.1016/j.ajcnut.2023.04.006. Epub 2023 Apr 11. PubMed PMID: 37044209; PubMed Central PMCID: PMC10447500.

select

Hoffman TL, Kershberg H, Goff J, Holmquist KJ, Haque R, Alvarado M. Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO. Fam Cancer. 2023 Apr;22(2):225-235. doi: 10.1007/s10689-022-00317-w. Epub 2022 Oct 20. PubMed PMID: 36261688; PubMed Central PMCID: PMC10020326.

select

Swope M, Alem AC, Russo SC, Gin NE, Chevez SG, Haque R. Developing a Community-Oriented and Place-Based Strategy to Improve COVID-19 Vaccine Accessibility. Perm J. 2023 Mar 15;27(1):103-112. doi: 10.7812/TPP/22.097. Epub 2023 Mar 13. PubMed PMID: 36911890; PubMed Central PMCID: PMC10015609.

select

Rosenthal A, Reddy S, Cooper R, Chung J, Zhang J, Haque R, Kim C. Disparities in melanoma-specific mortality by race/ethnicity, socioeconomic status, and health care systems. J Am Acad Dermatol. 2023 Mar;88(3):560-567. doi: 10.1016/j.jaad.2022.10.004. Epub 2022 Oct 11. PubMed PMID: 36228942.

select

Cooper RM, Chao C, Mukherjee A, Zhuang Z, Haque R. Influence of Comorbidity Burden, Socioeconomic Status, and Race and Ethnicity on Survival Disparities in Patients With Cancer. Cancer Control. 2023 Jan-Dec;30:10732748231204474. doi: 10.1177/10732748231204474. PubMed PMID: 37771179; PubMed Central PMCID: PMC10542233.

select

Haque R, Reading S, Irwin MR, Chen LH, Slezak J. Antidepressant medication use and prostate cancer recurrence in men with depressive disorders. Cancer Causes Control. 2022 Nov;33(11):1363-1372. doi: 10.1007/s10552-022-01623-5. Epub 2022 Sep 9. PubMed PMID: 36083407; PubMed Central PMCID: PMC9519663.

select

Chen LH, Irwin MR, Olmstead R, Haque R. Association of Physical Activity With Risk of Mortality Among Breast Cancer Survivors. JAMA Netw Open. 2022 Nov 1;5(11):e2242660. doi: 10.1001/jamanetworkopen.2022.42660. PubMed PMID: 36394875; PubMed Central PMCID: PMC9672970.

select

Kwan ML, Haque R, Young-Wolff KC, Lee VS, Roh JM, Ergas IJ, Wang Z, Cannavale KL, Ambrosone CB, Loo RK, Aaronson DS, Quesenberry CP, Kushi LH, Tang L. Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study. JAMA Netw Open. 2022 Nov 1;5(11):e2244430. doi: 10.1001/jamanetworkopen.2022.44430. PubMed PMID: 36449286; PubMed Central PMCID: PMC9713602.

select

Wallner LP, Chen LH, Hogan TA, Brasfield FM, Haque R. The Influence of Medical Comorbidities on Survival Disparities in a Multiethnic Group of Patients with De Novo Metastatic Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2022 Oct 4;31(10):1935-1943. doi: 10.1158/1055-9965.EPI-22-0065. PubMed PMID: 35861620.

select

Irwin MR, Olmstead R, Kruse J, Breen EC, Haque R. Association of interleukin-8 and risk of incident and recurrent depression in long-term breast cancer survivors. Brain Behav Immun. 2022 Oct;105:131-138. doi: 10.1016/j.bbi.2022.07.003. Epub 2022 Jul 5. PubMed PMID: 35803481.

select

Carroll JE, Olmstead R, Haque R, Irwin MR. Accelerated mononuclear cell telomere attrition in breast cancer survivors with depression history: A 2-year longitudinal cohort study. Cancer. 2022 Aug 15;128(16):3109-3119. doi: 10.1002/cncr.34329. Epub 2022 Jun 7. PubMed PMID: 35670038.

select

Haque R, Chlebowski RT, Chen L. Sleep medication use and risk of fractures in breast cancer survivors. Breast Cancer Res Treat. 2021 Dec;190(3):541-548. doi: 10.1007/s10549-021-06392-4. Epub 2021 Sep 29. PubMed PMID: 34586512; PubMed Central PMCID: PMC8558269.

select

Haque R, Hsu JW, Avila C, Olmstead R, Carroll JE, Irwin MR. Insomnia and Susceptibility to Depressive Symptoms and Fatigue in Diverse Breast Cancer Survivors. J Womens Health (Larchmt). 2021 Nov;30(11):1604-1615. doi: 10.1089/jwh.2019.8135. Epub 2020 Oct 9. PubMed PMID: 33035108; PubMed Central PMCID: PMC8917892.

select

Cooper RM, Chung J, Hogan T, Haque R. Patterns of overall mortality by race/ethnicity and socioeconomic status in insured cancer patients in Southern California. Cancer Causes Control. 2021 Jun;32(6):609-616. doi: 10.1007/s10552-021-01414-4. Epub 2021 Mar 30. PubMed PMID: 33783687; PubMed Central PMCID: PMC8089073.

select

Cooper RM, Chung J, Hogan T, Haque R. Influence of health care systems on mortality in adult patients with cancer. Am J Manag Care. 2021 May;27(5):182-185. doi: 10.37765/ajmc.2021.88631. PubMed PMID: 34002959.

select

Haque R, Chen L. SARS-CoV-2 Testing, Positivity Rates, and Healthcare Outcomes in a Cohort of 22,481 Breast Cancer Survivors. JCO Clin Cancer Inform. 2021 Feb;5:168-175. doi: 10.1200/CCI.20.00158. PubMed PMID: 33539175.

select

Lentz SE, Powell CB, Haque R, Armstrong MA, Anderson M, Liu Y, Jiang W, Chillemi G, Shaw S, Alvarado MM, Kushi LH, Skates SJ. Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations. Gynecol Oncol. 2020 Dec;159(3):804-810. doi: 10.1016/j.ygyno.2020.09.021. Epub 2020 Oct 1. PubMed PMID: 33012551.

select

Alvarado M, Tiller GE, Chung J, Haque R. Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan. J Community Genet. 2020 Jul;11(3):359-366. doi: 10.1007/s12687-020-00456-6. Epub 2020 Feb 24. PubMed PMID: 32096056; PubMed Central PMCID: PMC7295891.

select

Haque R, Skates SJ, Armstrong MA, Lentz SE, Anderson M, Jiang W, Alvarado MM, Chillemi G, Shaw SF, Kushi LH, Powell CB. Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutations. Gynecol Oncol. 2020 May;157(2):521-528. doi: 10.1016/j.ygyno.2020.02.027. Epub 2020 Mar 4. PubMed PMID: 32145911.

select

Roman M, Irwin MR. Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far. Brain Behav Immun. 2020 Jan;83:7-21. doi: 10.1016/j.bbi.2019.09.016. Epub 2019 Sep 21. Review. PubMed PMID: 31550500; PubMed Central PMCID: PMC6940145.

select

Chiang JJ, Cole SW, Bower JE, Irwin MR, Taylor SE, Arevalo J, Fuligni AJ. Daily interpersonal stress, sleep duration, and gene regulation during late adolescence. Psychoneuroendocrinology. 2019 May;103:147-155. doi: 10.1016/j.psyneuen.2018.11.026. Epub 2018 Dec 28. PubMed PMID: 30690224; PubMed Central PMCID: PMC8447850.

select

Xu X, Chlebowski RT, Shi J, Barac A, Haque R. Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors. Breast Cancer Res Treat. 2019 Apr;174(3):785-794. doi: 10.1007/s10549-018-05086-8. Epub 2019 Jan 18. PubMed PMID: 30659431; NIHMSID:NIHMS1041808.

select

Carroll JE, Van Dyk K, Bower JE, Scuric Z, Petersen L, Schiestl R, Irwin MR, Ganz PA. Cognitive performance in survivors of breast cancer and markers of biological aging. Cancer. 2019 Jan 15;125(2):298-306. doi: 10.1002/cncr.31777. Epub 2018 Nov 26. PubMed PMID: 30474160; PubMed Central PMCID: PMC7082843.

select

Haque R, Xu X, Shi J, Kwan ML, Chlebowski RT. Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women. Ethn Dis. 2018 Fall;28(4):565-574. doi: 10.18865/ed.28.4.565. eCollection 2018 Fall. PubMed PMID: 30405302; PubMed Central PMCID: PMC6200302.

select

Bradley MC, Zhou Y, Freedman AN, Yood MU, Quesenbery CP, Haque R, Van Den Eeden SK, Cassidy-Bushrow AE, Aaronson D, Potosky AL. Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer. Cancer Causes Control. 2018 Aug;29(8):785-791. doi: 10.1007/s10552-018-1050-z. Epub 2018 Jun 29. PubMed PMID: 29959604; PubMed Central PMCID: PMC6660131.

select

Sehrawat A, Gao L, Wang Y, Bankhead A 3rd, McWeeney SK, King CJ, Schwartzman J, Urrutia J, Bisson WH, Coleman DJ, Joshi SK, Kim DH, Sampson DA, Weinmann S, Kallakury BVS, Berry DL, Haque R, Van Den Eeden SK, Sharma S, Bearss J, Beer TM, Thomas GV, Heiser LM, Alumkal JJ. LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188. doi: 10.1073/pnas.1719168115. Epub 2018 Mar 26. PubMed PMID: 29581250; PubMed Central PMCID: PMC5939079.

select

Chao C, Silverberg MJ, Chen LH, Xu L, Martínez-Maza O, Abrams DI, Zha HD, Haque R, Said J. Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma. Leuk Lymphoma. 2018 Feb;59(2):321-329. doi: 10.1080/10428194.2017.1334121. Epub 2017 Jun 13. PubMed PMID: 28610450.

select

Haque R, Shi J, Telford C, Avila C, Chung J, Alvarado M, Tiller G, Ahmed S, Schottinger J, Dalvi T, Gutierrez L, Tyczynski J, Kaye J. Survival Outcomes in BRCA1/2 mutation carriers and the influence of triple negative breast cancer subtype. The Permanente journal. 2018; 22:17-187. doi: 10.7812/TPP/17-197.

select

Haque R, UlcickasYood M, Xu X, Cassidy-Bushrow AE, Tsai HT, Keating NL, Van Den Eeden SK, Potosky AL. Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study. Br J Cancer. 2017 Oct 10;117(8):1233-1240. doi: 10.1038/bjc.2017.280. Epub 2017 Aug 24. PubMed PMID: 29017178; PubMed Central PMCID: PMC5674100.

select

Fu AZ, Tsai HT, Haque R, Yood MU, Cassidy-Bushrow AE, Van Den Eeden SK, Keating NL, Smith MR, Zhou Y, Aaronson DS, Potosky AL. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer. J Urol. 2017 Jun;197(6):1448-1454. doi: 10.1016/j.juro.2016.12.086. Epub 2016 Dec 19. PubMed PMID: 28007467; PubMed Central PMCID: PMC5433922.

select

Haque R, Shi J, Chung J, Xu X, Avila C, Campbell C, Ahmed SA, Chen L, Schottinger JE. Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO. J Am Pharm Assoc (2003). 2017 May-Jun;57(3):303-310.e2. doi: 10.1016/j.japh.2017.01.004. Epub 2017 Mar 1. PubMed PMID: 28259737.

select

Pan K, Luo J, Haque R, Anderson G, Chlebowski R. Emerging common strategies to reduce breast and endometrial cancer risk. Medical journal of obstetrics and gynecology. 2017; 5:1105.

select

Griggs JJ, Hamilton AS, Schwartz KL, Zhao W, Abrahamse PH, Thomas DG, Jorns JM, Jewell R, Saber ME, Haque R, Katz SJ. Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample. Breast Cancer Res Treat. 2017 Jan;161(2):375-384. doi: 10.1007/s10549-016-4061-z. Epub 2016 Nov 29. PubMed PMID: 27900490; PubMed Central PMCID: PMC5902386.

select

Fu AZ, Tsai HT, Haque R, Ulcickas Yood M, Van Den Eeden SK, Cassidy-Bushrow AE, Zhou Y, Keating NL, Smith MR, Aaronson DS, Potosky AL. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World J Urol. 2016 Dec;34(12):1611-1619. doi: 10.1007/s00345-016-1823-5. Epub 2016 Apr 15. PubMed PMID: 27084777; PubMed Central PMCID: PMC5065786.

select

Haque R, Shi J, Schottinger JE, Chung J, Avila C, Amundsen B, Xu X, Barac A, Chlebowski RT. Cardiovascular Disease After Aromatase Inhibitor Use. JAMA Oncol. 2016 Dec 1;2(12):1590-1597. doi: 10.1001/jamaoncol.2016.0429. PubMed PMID: 27100398.

select

Kwan ML, Shi JM, Habel LA, Song J, Chung JW, Avila CC, Schottinger JE, Cheetham TC, Fletcher SW, Haque R. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr;156(2):379-89. doi: 10.1007/s10549-016-3763-6. Epub 2016 Mar 22. PubMed PMID: 27002508.

select

Chlebowski RT, Anderson GL, Sarto GE, Haque R, Runowicz CD, Aragaki AK, Thomson CA, Howard BV, Wactawski-Wende J, Chen C, Rohan TE, Simon MS, Reed SD, Manson JE. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. J Natl Cancer Inst. 2016 Mar;108(3). doi: 10.1093/jnci/djv350. Print 2016 Mar. PubMed PMID: 26668177; PubMed Central PMCID: PMC5072373.

select

Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, Avila C, Kleinman K, Habel LA, Fletcher SW, Kwan ML. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016 Mar;108(3). doi: 10.1093/jnci/djv337. Print 2016 Mar. PubMed PMID: 26631176; PubMed Central PMCID: PMC5072369.

select

Gordon M, Curtis C, Henricksen L, Barnes M, Weng P, Seoane J, Shi J, Haque R, Press M. MYST2 gene co-amplification in HER2-amplified breast cancers: Potential Association with Tamoxifen Resistance. Cancer discovery. 2016.

select

Collins LC, Achacoso N, Haque R, Nekhlyudov L, Quesenberry CP Jr, Schnitt SJ, Habel LA, Fletcher SW. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S502-8. doi: 10.1245/s10434-015-4641-x. Epub 2015 Jun 10. PubMed PMID: 26059650.